The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: An analysis from the breathing not properly multinational study

Diabetes Care

Volumn 27, Issue 10, 2004, Pages 2398-2404

  Wu, Alan H B ^a,j   Omland, Torbjørn ^b   Duc, Philippe ^c   McCord, James ^d   Nowak, Richard M ^d   Hollander, Judd E ^e   Herrmann, Howard C ^e   Steg, Philippe G ^c   Wold Knudsen, Cathrine ^b   Storrow, Alan B ^f   Abraham, William T ^g   Perez, Alberto ^a   Kamin, Richard ^a   Clopton, Paul ^h   Maisel, Alan S ^h   McCullough, Peter A ⁱ  

^a HARTFORD HOSPITAL   (United States)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c BICHAT HOSPITAL   (France)

^d HENRY FORD HOSPITAL   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WILLIAM BEAUMONT HOSPITAL   (United States)

^j SAN FRANCISCO GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; AGED; ANAMNESIS; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DYSPNEA; EMERGENCY WARD; FEMALE; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE COMPLIANCE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX RATIO;

ACUTE DISEASE; AGE FACTORS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 4644253381     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.10.2398     Document Type: Article

References (24)

1. American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. Diabetes Care 21:1551-1559, 1998
2. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29-34, 1974
3. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades E, Howard BV: Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 101:2271-2276, 2000
4. Spector KS: Diabetic cardiomyopathy. Clin Cardiol 21:885-887, 1998
5. Bell DSH: Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26:2433-2441, 2003
6. Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-832, 1998
7. Murdock DR, McDonagh TA, Byrne J, Blue L, Farmer R, Morton JJ, Dargie HJ: Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 139:1126-1132, 1999
8. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDOnagh T, Mair J, Nieminen M, Francis G: Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24:1710-1718, 2003
9. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A: Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26: 2081-2087, 2003
10. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Wold Knudsen C, Perez A, Kazanegra R, Herrmann HC, McCollough PA, BNP Multinational Study Investigators: Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure: primary results from the Breathing Not Properly (BNP) Multinational Study. N Engl J Med 347:161-167, 2002
11. McCullough PA, Duc P, Omland T, McCord J, Nowak RM Hollander JE, Herrmann HC, Steg PG, Westheim A, Wold Knudsen C, Storrow AB, Abraham WT, Lamba S, Wu AHB, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS, BNP Multinational Study Investigators: B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kid Diseases 41: 571-579, 2003
12. Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PWF, Sutherland P, Omland T, Vasan RS: Impact of age and sex on plasma natriuretic peptide levels in adults. Am J Cardiol 90:254-258, 2002
13. Wieczorek SJ, Wu AHB, Christenson R, Rosano T, Hager D, Bailly K, Dahlen J, Chambers BS, Maisel A: A rapid B-type natriuretic peptide (BNP) assay accurately diagnoses left ventricular dysfunction and heart failure: a multi-center evaluation. Am Heart J 144:834-839, 2002
14. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:1004-1010, 2002
15. McMurray JV, McDonagh TA, Davie AP, Cleland JGF, Francis CM, Morrison C: Should we screen for asymptomaic left ventricular dysfunction to prevent heart failure? Eur Heart J 19:842-846, 1998
16. McDonagh TA. Screening for left ventricular dysfunction: a step too far? Heart 88 (Suppl. 2ii):12-14, 2002
17. McDonagh T, Robb SD, Murdock DR, Morton JJ, Ford I, Morrison CE, Thunstall-Pedoe H, McMurray JJV, Dargie HJ: Biochemical detection of left ventricular dysfunction. Lancet 351:9-13, 1998
18. Kasan R, Benjamin E, Larson MG, Leip EP, Wang TJ, Wilson PWF, Lev D: Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham Heart Study. JAMA 288:1252-1259, 2002
19. Yano Y, Katsuki A, Gabazza EC, Ito K, Fujii M, Furuta M, Tuchihashi K, Goto H, Nakatani K, Hori Y, Sumida Y, Adachi Y: Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 84:2353-2356, 1999
20. Nagai T, Imamura M, Inukai T, Mori M: Brain natriuretic polypeptide in type 2 diabetes patients with albuminuria. J Med 32:169-180, 2001
21. Siebenhofer A, Ng LL, Plank J, Berghold A, Hodl R, Pieber TR: Plasma N-terminal pro-brain natriuretic peptide in type 1 diabetic patients with and without diabetic nephropathy. Diabet Med 20:535-539, 2003
22. Chan NN, Hurel SJ: Brain natriuretic peptide as a potential marker of diastolic dysfunction in type 2 diabetes (Letter). Diabetes Care 24:2019-2020, 2001
23. Poirer P, Bogaty P, Garneau C, Marois L, Dumesnil JG: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:5-10, 2001
24. McKenna K, Smith D, Moore K, Glen A, Tormey W, Thompson CJ: Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in type 1 diabetes mellitus. Diabet Med 18: 973-978, 2001